Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 23

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 23
---
 Dr. Matthew Del Giudice, each until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal. For more information about the executive officers and directors of TELO following the Merger, please see the section titled “ Management Following the Merger.”

Interests of the TELO Directors, Executive Officers and Affiliate Shareholders in the Merger (see page 34)

In considering the recommendation of the TELO Board with respect to the issuance of TELO Common Stock pursuant to the Merger Agreement and the other matters to be acted upon by TELO’s stockholders at the TELO Annual Meeting, TELO’s stockholders should be aware that certain members of the TELO Board and executive officers of TELO have interests in the Merger that may be different from, or in addition to, interests of other TELO stockholders.

As of November 18, 2025, TELO’s directors and executive officers (including affiliates) beneficially own in the aggregate approximately 18.76% of the outstanding shares of TELO Common Stock.

The conflicts of interests of TELO’s officers and directors in connection with the Merger, and certain related party transactions, are discussed in greater detail in the section titled “ The Merger—Interests of the TELO Directors, Executive Officers and Affiliate Shareholders in the Merger” on page 34 of this proxy statement.

Material U.S. Federal Income Tax Consequences of the Merger (see page 36)

TELO and TELI intend the Merger to qualify as a reorganization within the meaning of Section 368(a) of the Code, as described in the section titled “ The Merger—Material U.S. Federal Income Tax Consequences of the Merger.” If the Merger qualifies as a reorganization within the meaning of Section 368(a) of the Code, TELI stockholders will not recognize gain or loss for U.S. federal income tax purposes on the receipt of shares of TELO Common Stock issued in connection with the Merger.

Regulatory Approvals Required for the Merger

In the United States, TELO must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of TELO Common Stock to TELI’s stockholders in connection with the Merger and the filing of this proxy statement with the SEC.

For more information, please see the section titled “ The Merger—Regulatory Approvals Required for the Merger.”

Risk Factors